Nalaganje...
Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment
Despite the recent substantial improvement of clinical outcome in mantle cell lymphoma (MCL), resistance to immunochemotherapy and common relapses are challenges for long-term tumor control. The assessment of minimal residual disease (MRD) by real-time quantitative polymerase chain reaction has emer...
Shranjeno v:
| izdano v: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142459/ https://ncbi.nlm.nih.gov/pubmed/27913513 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|